Skip to main content

Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

The Original Article was published on 11 September 2020

Correction to: BMC Gastroenterology (2020) 20:296 https://doi.org/10.1186/s12876-020-01441-6

After publication of this article [1], the authors reported three adjustments:

  1. 1.

    Competing interests: the travel grants were paid by HLW Pharma instead of TEVA Pharma.

  2. 2.

    TGN-units all over the manuscript have to be adjusted from pmol/8 × 105 RBC to pmol/8 × 108 RBC.

  3. 3.

    Some minor textual adjustments.

The original article [1] has been updated.

Reference

  1. Bayoumy AB, van Liere ELSA, Simsek M, et al. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterol. 2020;20:296. https://doi.org/10.1186/s12876-020-01441-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed B. Bayoumy.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bayoumy, A.B., van Liere, E.L.S.A., Simsek, M. et al. Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterol 22, 208 (2022). https://doi.org/10.1186/s12876-021-01992-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12876-021-01992-2